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[1], where global trends in the distribution of Candida species
causing candidemia are reviewed. The article underscores that
the epidemiology of candidemia in terms of distribution of
Candida species has evolved over time and may exhibit notable
differences in different geographic areas and among different
hospital units, whereby candidemia may sometimes be due to
epidemic strains that are cross-transmitted from patient to
patient.
The overall burden of candidemia can be different in different
wards and hospital settings, and in our experience, great differ-
ences in the incidence of candidemia can be encountered within
the same hospital and between the same wards of different
hospitals. Data from the SENTRY Antimicrobial Surveillance
Program showed that 44.5% of candidemias were acquired in the
intensive care unit (ICU) in the 2008–2009 period [2]. In the
past, candidemia was not frequently documented in medical
wards (MWs). For instance, in the 1990s, Luzzati et al. [3] re-
ported that only 6.5% of candidemia were found in MWs. More
recently, however, several epidemiologic surveys performed in
different countries have reported higher proportions of candi-
demia in MWs than in ICUs (Supplementary Table S1). Com-
parison of the burden of candidemia in different hospital settingsClinical Microbiology and Infection © 2015 European Society of Cby the analysis of the rate of candidemia per 10 000 days of
hospital stay per year revealed a notable diversity: from 0.73 to
4.4 in the overall hospital population, and from 0.7 to 23.1 in
ICUs, while data forMWswere available only from one study [4].
We analysed the incidence of candidemia observed over a
2-year period (2012–2013) in three large tertiary-care uni-
versity hospitals located in central and northern Italy. Because
in Italy the hospital organization may be quite different from
other countries, we analysed the incidence of candidemia not
only for MWs overall but also separately for general MWs and
specialized MWs, which included wards of specialized medicine
(e.g. pneumology, nephrology, infectious diseases) where
younger patients with fewer comorbidities are likely to be
admitted, with respect to general MWs.
Results of the analysis, listed in Table 1, revealed notable
differences, including in the overall incidence of candidemia in
different hospitals (range 1.65–3.45 candidemia per 10 000
days of admission per year); in the incidence of candidemia in
ICUs of different hospitals (range 2.06–12.45 candidemia per
10 000 days of admission per year); in the incidence of candi-
demia in general MWs of different hospitals (range 1.3–10.2
candidemia per 10 000 days of admission per year); and in the
incidence of candidemia in surgical wards of different hospitals
(range 1.05–3.9 candidemia per 10 000 days of admission per
year). On the other hand, the incidence of candidemia in
specialized MWs was similar in the three hospitals. The inci-
dence of candidemia in general MWs vs. ICUs was lower (in
two hospitals) or similar (in one hospital).
These differences may reﬂect different hospital organization
and practices and/or the circulation of epidemic strains of
Candida inside the wards or inside different hospitals. In
particular, the higher incidence of candidemia observed in some
general MWs may be due to admissions of elderly patients with
underlying conditions, who are often treated with broad-
spectrum antibiotics and frequently treated with parenteral
nutrition administered by a central venous catheter. In fact,
underlying malignancies, immunosuppressive and steroid ther-
apy, hematopoietic stem cell or solid organ transplantation,
broad-spectrum antibiotics, central venous catheter or periph-
eral intravenous central catheter, anticancer chemotherapy and
parenteral nutrition are known to be among the most important
factors that increase the risk of invasive candidiasis [5].
Moreover, the governance models adopted by Italian re-
gions, including Tuscany and Friuli, where the three hospitals
are located, is based on a performance evaluation system that
included 14 indicators. Among these indicators, two are the
ordinary hospitalization rate and percentage of short medical
hospitalizations. Therefore, a hospital where MWs have aClin Microbiol Infect 2015; 21: e71–e72
linical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved
http://dx.doi.org/10.1016/j.cmi.2015.05.019
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Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectshorter median length of stay is evaluated as being better than a
hospital with a longer length of stay in MWs. Therefore, many
patients are discharged sooner to home or to a long-term care
facility with a central venous catheter in order to permit venous
access for providing parenteral nutrition and intravenous
therapy. This catheter may be a tremendous risk factor for
candidemia. The shorter length of stay in general MWs of two
of the three hospitals could be related to the higher incidence
of candidemia observed in these cases.Transparency declarationAll authors report no conﬂicts of interest relevant to this
article.Appendix A. Supplementary dataSupplementary data related to this article can be found online at
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